AzTrials
AzTrials

Breast CancerNCT03578484

Breast Aesthetics by Three Dimensional Measures

An observational study of Breast Cancer, run by Sykehuset Telemark at 2 sites in Norway.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Traditionally the measures of the optimally aesthetic breast have been assumed to be static and to represent universal values (1). Measures developed for optimal aesthetic results in breast reduction were derived from brassiere patterns and then applied universally (2). Read more about this study

Who is it for?
Ages 18 to 35 years, women only
Conditions the study is for
Breast Cancer
What is being tested?
Aesthetic assessment 3D breast scanning
How many people
32 participants
Where
2 sitesNorway
Study dates
13 May 2016to 20 Mar 2032
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 35 years
  • Women only
  • Adult

Study population: The study will be based on female volunteers between the ages of 18 and 35 of all races. This age range incorporates early to late youth. It also allows for sequential follow up. Patients with breast cancer treatment, removal of non-malignant masses, trauma, burns or dermatological diagnoses involving the breast were excluded from the study. Subjects with cosmetic surgery will be allowed to participate in the study. Volunteers will be recruited from nursing staff at Telemark Health Trust, nursing students from University Southeast Norway in Porsgrunn Norway.

Who may be able to join

  • The study will be based on female volunteers between the ages of 18 and 35 of all ethnic backgrounds.

Who cannot join

  • Patients with breast cancer treatment, removal of non-malignant masses, trauma, burns or dermatological diagnoses involving the breast are excluded from the study.

Trial locations and contacts

2 sites in 1 country.

Norway2 sites
  • Oslo University Hospital

    Oslo, 0424

  • Sykehuset Telemark

    Skien, Telemark, NO-3710

Other trials in Norway

About this study

Official title: Breast Aesthetics by Three Dimensional Measures - A Transatlantic Evaluation of Beauty Ideals Using 3D Scanning and Mammometrics.

Traditionally the measures of the optimally aesthetic breast have been assumed to be static and to represent universal values (1). Measures developed for optimal aesthetic results in breast reduction were derived from brassiere patterns and then applied universally (2). These early and important papers still strongly influence the view of the aesthetics of the breast despite the lack of individualisation and proportion.

To create satisfying results for specific patients, optimal proportions angles and relative measures are needed for each patient. The study will clarify theses measures and provide important guidelines for surgeons.The data will also help define optimal proportional aesthetics in the individual patient.

Read more

The concept of universal beauty is unrealistic. It has always been taken for granted that aesthetic values from all cultures are similar. Using 3D scanning on volunteers of youthful age offers a complex set of data that may distinguish fine differences in aesthetic ideals in different cultures.

Little is known about how life events and life-style factors affect breast aesthetics.

To follow a population with 3D scans over 5, 10 and 15 years will allow aesthetic ratings to be correlated with life events such as pregnancy, childbirth, breast-feeding and life style factors such as smoking.

The study will improve the understanding of breast aesthetics in general, in different cultures and in relation to life events and life style factors. No similar studies have previously been performed.

Read the detailed description

Aims for the study:

To identify aesthetic factors that contribute to overall beauty and aesthetics of the breast.

To identify proportions and measures of the most aesthetically pleasing breast and also of the least appealing breast. This will provide a guideline and a map for the reconstructive breast surgeon in what to aim for and what to avoid in the breast reconstructive process.

To identify cultural differences in the perception of beauty.

Aims for the longitudinal part of the study:

To identify lifestyle and life event factors that independently influences the progression of cosmetic ratings and 3D measurements of the breast over 5, 10 and 15 years.

To identify trends and differences in aesthetic ratings of the same 3D scans over time.

Data collection:

At the initial and all following controls of the study a short patient interview will be conducted to obtain the following information:

Subject demographics:

Age, Race, Previous Medical History, Number of Childbirths, Breast feeding - how many children - how many months per child, Surgeries of the breast, Surgeries of the chest wall, Weight, Height, Bra Size, Sports bra use - always - during sports - rarely - never, Smoking, alcohol, Occupation, Physical activity

Measures of the breast will be obtained by 3D scanning.

Rating of the 3D scans will be performed by eight assigned teams:

10 Plastic Surgeons from Scandinavia, 10 Plastic Surgeons from Texas, 10 Scandinavian nurses without formal aesthetic or plastic surgery training, 10 Nurses and/or Physician assistants from the USA without formal aesthetic or plastic surgery training, 10 Medical Students from Texas, 10 Medical Students from Scandinavia, 10 Nursing Students from Texas, 10 Nursing Students from Scandinavia

The 3D scans will be aesthetically rated by independent evaluators on a scale from 1-5. The vertical split plane and the horizontal split plane as defined by Tepper et al (8) in mammometrics will be used to subdivide the breast into aesthetic units.

A separate rating will be obtained for each breast:

Lower pole 1-5, Upper pole 1-5, Medial pole 1-5, Lateral pole 1-5, Nipple position 1-5, Areola color 1-5, Areola size 1-5, Breast footprint position, Overall score

Also both breasts together will be scored regarding:

Intermammary distance / breast cleft, symmetry, overall bilateral score

Data Storage:

The data will be stored for 16 years. The data will be stored in a password -protected computer with firewall protection. The data will be stored in a locked safe.

Statistics:

We will use descriptive statistics such as mean and standard deviation. Various subgroup analyses may occur - continuous variables will be compared using the two sample T-test and parametric variables will be compared using chi-squared analysis or Fischer's exact test. Univariate and multivariate regression models will be used to analyze for confounding factors.

The statistical calculations will be performed in Norway at the Dept of statistics at Rikshospitalet Oslo and/or in collaboration with MD Anderson Cancer Center in Texas, USA.

The rating-system for aesthetics will be tested for reliability. Ten raters will be rating 30 of the same 3D scans twice with a 2 week interval.

Calculation of necessary number of participating women (n) as determined in collaboration with the Dept of Statistics Oslo University:

In the present study a mean score of "overall score bilateral breasts" will be compared in 10 American (Group 1, 3, 5, 7) and 10 Scandinavian/Norwegian (Group 2, 4, 6, 8) plastic surgeons/nurses/medical students/nursing students. We define a mean "overall score bilateral breasts" score difference of at least 0.5 to be a difference of statistical significance. Significance will be defined as p = 0.05. In order to perform a power calculation we need an estimate of the standard deviation (SD) of the scoring of "overall score bilateral breasts" within each group. However such estimates are not available in the literature. We therefore will use the following procedure to calculate (n):

Step 1: Include 10 women and measure average score on "overall score bilateral breasts" for each plastic surgeon. Then calculate SD for each of the average scores in each group. Then we will use these estimates of SD in a power calculation, and calculate the (n) associated with a test power of 80% as per Sandvik.

Our preliminary estimation of power is 150 patients. The somewhat high number is due to potential drop out rates for the longitudinal arm of the study.

Organisation:

Principal Investigator and Conceptual Author: LJ Sandberg Telemark Hospital Trust, Dept of Plastic Surgery, Norway

Collaborators:

Senior author: JC Selber MD Anderson Cancer Center, USA Other authors in random order: G Reece MD Anderson Cancer Center, USA; K Kloster Jensen Telemark Hospital Trust Dept of Plastic Surgery; T Bernklev Telemark Hospital Trust, Dept of Research, Norway; L Sandvik Oslo University, Dept of Statistics, Norway; G Gunnarson Telemark Hospital Trust, Dept of Plastic Surgery, Norway; E Berg Telemark Hospital Trust, Dept of Plastic Surgery, Norway; K Tønseth, Oslo University Hospital, Dept of Plastic Surgery, Norway; HP Gullestad, Oslo University Hospital, Dept of Plastic Surgery, Norway; M Halle Dept of Plastic Surgery, Karolinska Institute Sweden; Å Edsander Nord Dept of Plastic Surgery, Karolinska Institute Sweden; A Höckerstedt Dept of Plastic Surgery, University of Helsinki, Finland; S Kauhanen Dept of Plastic Surgery, University of Helsinki, Finland; E Holm Hansen University Southeast Norway, Norway; Karin Berntsen University Southeast Norway, Norway; Plastic Surgical Department of Statistics at MD Anderson Cancer Center , USA; Department of Statistics at Oslo University, Norway

Canfield Inc / Skintech are not active partners in the project, just partners supplying technology and support. The name of the 3D Vectra system will be used in the paper to scientifically describe the study. Canfield Inc will be mentioned in the Method section of the study as contributing to the study and any conflicts of interests will be disclosed in all and any presentations and publications. No funds have been received from Canfield Inc. Canfield Inc has allowed use of the Vectra 3D camera in the study without any demands or charges.

Clinical Importance:

Aesthetic measures are the basis of all plastic surgical breast procedures and this study will have a major influence on all of plastic surgical procedures of the breast - particularly breast reconstruction. Determining a difference between aesthetic ratings in different cultures would further stress the concept of "beauty lying in the eye of the beholder" and that beauty concepts have to be adapted to the individual and not the other way around. Beauty is not one strict measure, but a range of measures and proportions adapted to the individual subject. The use of 3D scanning is a new technique that offers superior quality documentation and preoperative analysis. The study will further define 3D scanning as a new standard for aesthetic breast evaluations.

In the long term follow up the factors affecting aesthetic ratings over time (aging of the breast), such as smoking, would be revealed. This could further allow life style choices to be made by patients promoting breast aesthetics and hopefully health in general.

Conditions
Breast Cancer
Being tested
Aesthetic assessment 3D breast scanning
Keywords
Breast Aesthetics, 3D scanning, Aesthetic rating, Cultural Differences Aesthetics, Mammometrics
Medical subject headings
Breast Neoplasms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Aesthetic assessment 3D breast scanningDiagnostic test

    Vectra TM - Canfield Inc breast scan. 3D digital photography scan.

Study groups in NCT03578484
Study groupRoleWhat they receive
Volunteer female subjectsFemales age 18-35 years of age. 3D breast scan will be performed and followed over 15 years. No therapeutic interventions will be performed.
Receives: Diagnostic Test: Aesthetic assessment 3D breast scanning

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Breast aesthetic score in Scandinavia

    Using a rating system developed by Sandberg and Selber for this project, each individual breast (left and right) will be scored according to aesthetic aspects. A score ranging from 1 lowest to 5 highest will be given by the rater. The parameters rated will be breast size, breast width, breast height, breast position, nipple position, nipple shape, nipple color and breast shape.

    The score will be the outcome measure for the most pleasant aesthetics.

    Measured: 5 years

  2. Breast measures in centimeters and degrees in Scandinavia

    The highest and lowest scored breasts will be measured. Anatomic measures of the breast between fiduciary points, such as distance the nipple and the sternal notch in centimeters. Also measures of angles between the midline and nipple position measured in degrees. Also measures of curvatures in degrees and vectors. The measures will be performed digitally on the 3D scans obtained by the Vectra system for 3D scanning using the software developed by Canfield Inc.

    This will be the outcome measure in centimeters, degrees and proportions.

    Measured: 5 years

  3. Breast aesthetic score in USA

    Using a rating system developed by Sandberg and Selber for this project, each individual breast (left and right) will be scored according to aesthetic aspects. A score ranging from 1 lowest to 5 highest will be given by the rater. The parameters rated will be breast size, breast width, breast height, breast position, nipple position, nipple shape, nipple color and breast shape.

    The score will be the outcome measure for the most pleasant aesthetics in the USA.

    Measured: 5 years

  4. Breast measures in centimeters and degrees in USA

    The highest and lowest scored breasts will be measured. Anatomic measures of the breast between fiduciary points, such as distance the nipple and the sternal notch in centimeters. Also measures of angles between the midline and nipple position measured in degrees. Also measures of curvatures in degrees and vectors. The measures will be performed digitally on the 3D scans obtained by the Vectra system for 3D scanning using the software developed by Canfield Inc.

    This will be the outcome measure in centimeters, degrees and proportions for USA.

    Measured: 5 years

Secondary outcomes (6)
  1. Breast measures in centimeters and degrees changes at 5 years

    The highest scored breasts will be measured. Anatomic measures of the breast between fiduciary points, such as distance the nipple and the sternal notch in centimeters. Also measures of angles between the midline and nipple position measured in degrees. Also measures of curvatures in degrees and vectors. The measures will be performed digitally on the 3D scans obtained by the Vectra system for 3D scanning using the software developed by Canfield Inc.

    This will be the outcome measure in centimeters, degrees and proportions to detect change after 5 years.

    Measured: 10 years

  2. Breast measures in centimeters and degrees changes at 10 years

    The highest scored breasts will be measured. Anatomic measures of the breast between fiduciary points, such as distance the nipple and the sternal notch in centimeters. Also measures of angles between the midline and nipple position measured in degrees. Also measures of curvatures in degrees and vectors. The measures will be performed digitally on the 3D scans obtained by the Vectra system for 3D scanning using the software developed by Canfield Inc.

    This will be the outcome measure in centimeters, degrees and proportions to detect change after 10 years.

    Measured: 15 years

  3. Breast measures in centimeters and degrees changes at 15 years

    The highest scored breasts will be measured. Anatomic measures of the breast between fiduciary points, such as distance the nipple and the sternal notch in centimeters. Also measures of angles between the midline and nipple position measured in degrees. Also measures of curvatures in degrees and vectors. The measures will be performed digitally on the 3D scans obtained by the Vectra system for 3D scanning using the software developed by Canfield Inc.

    This will be the outcome measure in centimeters, degrees and proportions to detect change after 15 years.

    Measured: 16 years

  4. Change in breast aesthetic score at 5 years

    Using a rating system developed by Sandberg and Selber for this project, each individual breast (left and right) will be scored according to aesthetic aspects. A score ranging from 1 lowest to 5 highest will be given by the rater. The parameters rated will be breast size, breast width, breast height, breast position, nipple position, nipple shape, nipple color and breast shape.

    The score will be the outcome measure for the change of aesthetics over 5 years.

    Measured: 10 years

  5. Change in breast aesthetic score at 10 years

    Using a rating system developed by Sandberg and Selber for this project, each individual breast (left and right) will be scored according to aesthetic aspects. A score ranging from 1 lowest to 5 highest will be given by the rater. The parameters rated will be breast size, breast width, breast height, breast position, nipple position, nipple shape, nipple color and breast shape.

    The score will be the outcome measure for the change of aesthetics over 10 years.

    Measured: 15 years

  6. Change in breast aesthetic score at 15 years

    Using a rating system developed by Sandberg and Selber for this project, each individual breast (left and right) will be scored according to aesthetic aspects. A score ranging from 1 lowest to 5 highest will be given by the rater. The parameters rated will be breast size, breast width, breast height, breast position, nipple position, nipple shape, nipple color and breast shape.

    The score will be the outcome measure for the change of aesthetics over 15 years.

    Measured: 16 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Jul 2018
  2. Study start13 May 2016
  3. Primary completion20 Mar 2032 (estimated)
  4. Study completion20 Mar 2032 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
32 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03578484
Sponsor's protocol ID
44059 / 3 / MSS
Status last verified
Jul 2025
First submitted
25 Apr 2018
Last updated
4 Jul 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • PENN J. Breast reduction. Br J Plast Surg. 1955 Jan;7(4):357-71. doi: 10.1016/s0007-1226(54)80046-4. No abstract available.

    PubMed 13230442
  • WISE RJ. A preliminary report on a method of planning the mammaplasty. Plast Reconstr Surg (1946). 1956 May;17(5):367-75. doi: 10.1097/00006534-195605000-00004. No abstract available.

    PubMed 13335513
  • Loughry CW, Sheffer DB, Price TE Jr, Lackney MJ, Bartfai RG, Morek WM. Breast volume measurement of 248 women using biostereometric analysis. Plast Reconstr Surg. 1987 Oct;80(4):553-8. doi: 10.1097/00006534-198710000-00013.

    PubMed 3659165
  • Loughry CW, Sheffer DB, Price TE, Einsporn RL, Bartfai RG, Morek WM, Meli NM. Breast volume measurement of 598 women using biostereometric analysis. Ann Plast Surg. 1989 May;22(5):380-5. doi: 10.1097/00000637-198905000-00002.

    PubMed 2729845
  • Smith DJ Jr, Palin WE Jr, Katch VL, Bennett JE. Breast volume and anthropomorphic measurements: normal values. Plast Reconstr Surg. 1986 Sep;78(3):331-5. doi: 10.1097/00006534-198609000-00008.

    PubMed 3737757
  • Losken A, Seify H, Denson DD, Paredes AA Jr, Carlson GW. Validating three-dimensional imaging of the breast. Ann Plast Surg. 2005 May;54(5):471-6; discussion 477-8. doi: 10.1097/01.sap.0000155278.87790.a1.

    PubMed 15838205
  • Tepper OM, Small K, Rudolph L, Choi M, Karp N. Virtual 3-dimensional modeling as a valuable adjunct to aesthetic and reconstructive breast surgery. Am J Surg. 2006 Oct;192(4):548-51. doi: 10.1016/j.amjsurg.2006.06.026.

    PubMed 16978973
  • Tepper OM, Unger JG, Small KH, Feldman D, Kumar N, Choi M, Karp NS. Mammometrics: the standardization of aesthetic and reconstructive breast surgery. Plast Reconstr Surg. 2010 Jan;125(1):393-400. doi: 10.1097/PRS.0b013e3181c4966e. No abstract available.

    PubMed 20048631
  • Rohrich RJ, Bolden K. Ethnic rhinoplasty. Clin Plast Surg. 2010 Apr;37(2):353-70. doi: 10.1016/j.cps.2009.11.006.

    PubMed 20206751
  • Li Z, Unger JG, Roostaeian J, Constantine F, Rohrich RJ. Individualized Asian rhinoplasty: a systematic approach to facial balance. Plast Reconstr Surg. 2014 Jul;134(1):24e-32e. doi: 10.1097/PRS.0000000000000294.

    PubMed 25028852

Questions about this trial

What is this clinical trial studying?

An observational study of Breast Cancer, run by Sykehuset Telemark at 2 sites in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 4 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Breast aesthetic score in Scandinavia (time frame: 5 years). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03578484, which also lists 10 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Jul 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in